Patents on vaccines and on new technologies against COVID-19 are the ball and chain in the race out of the global pandemic tunnel. Our lives are worth more than the profits of big pharmaceutical companies.
In this final and decisive phase of trials, the objective is to evaluate the efficacy, safety and immunogenicity of Soberana 02. If the vaccine produces fruitful results, Cuba will become the first country in the Latin American and the Caribbean region to develop its own vaccine
Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the challenges of taking a vaccine to the people in countries like India. They also look at the various vaccine candidates in contention
Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the phenomenon of reinfection of COVID-19
Cuba’s vaccine candidate is the first from the Latin America and the Caribbean region and marks a continuation of its pioneering work in combating COVID-19 across the world